BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 10, 2014
View Archived Issues
Eisai presents highlights of third quarter of fiscal 2013
Read More
Astellas reflects on accomplishments of third quarter of fiscal 2013
Read More
Researchers report data from phase I/II study of retinal gene therapy in patients with choroideremia
Read More
Ono Pharmaceutical updates milestones of third quarter of fiscal 2013
Read More
Phase II results show prolonged immune responses with DN24-02 in patients with urothelial cancer
Read More
Mutant recombinant protective antigen vaccine protects animals from anthrax
Read More
Hisamitsu Pharmaceutical reports data from phase II study of HP-3000
Read More
AnGes prepares global phase III study of Collategene
Read More
Takeda reports development of 5-HT3 receptor antagonists
Read More
Dainippon Sumitomo Pharma patent describes coagulation factor XIa inhibitor
Read More
e-Therapeutics begins dosing in phase I study of oral ETS-2101
Read More
Chinese researchers patent novel CETP inhibitors
Read More
Kyowa Hakko Kirin alters supplemental application for Poteligio in Japan
Read More
Metabrain Research divulges compounds with potential for treatment of type 2 diabetes
Read More
Alcobra files IND to conduct phase III trial of MG-01CI in adults with ADHD
Read More
Ares Trading patent reports novel gamma-secretase modulators
Read More
Soluble guanylate cyclase activators reported in Bayer patent
Read More
Pfizer to perform phase Ib trial of PF-06342674 in MS
Read More
Novartis researchers reveal histamine H3 receptor antagonists
Read More
Hutchison MediPharma discloses novel PI3Kdelta inhibitors
Read More
Asthma treatment flutiform launched in France
Read More
MLN-7243 to be evaluated in phase I cancer trial
Read More
FDA grants orphan drug designation to NeuroVax for pediatric MS
Read More
Eravacycline demonstrates efficacy in animal models of Francisella tularensis infection
Read More
Phase II study data do not support development of ADX-71149 for anxious depression
Read More